Rebel
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SARS-CoV-2 (COVID-19)testing IS now available at Arrayit. They don't have to be on your list!
http://www.arrayit.com/SARS-CoV-2COVID-19TestInstructions.pdf
Very simple. They call their doctor, their doctor or his assistant would take a fingerprick blood sample (4 drops of blood on a blood card), and then mail it to Arrayit for testing. Results in 24-48 hours via Arrayit's Patient Portal.
No patent is needed. The company uses their proprietary microarray technology platform for sampling and testing.
Crazy, I agree. We are living in a Stephen King novel. LOL.
If they did NOT have the Covid-19 test available, it would NOT appear on their website. Duh.
"Hello? OK, could I have two BigMacs, 3 Happy Meals, and 5 COVID-19 test kits. Oh, please throw in some extra salt and ketchup."
"No problem, and thank you for you order."
If you read the instructions, it refers to "patient's" over and over again, and to me that means, at least for now, the test is available to all of the doctors, clinics, and other service providers that are already registered with the portal, i.e., "wash the patient's hands with soap and warm water; "gently squeeze your patient's hand and finger to increase blood flow," and "soak all 4 blood card circles completely with your patient’s blood as shown; "blot your patient’s finger tip with the gauze pad and cover with a bandage, 6. Insert the blood card containing your patient’s blood sample into the silver envelope.
Soon, the test may be available to the public, but maybe not quite yet. Not sure how many are signed up with the portal, but it must be at least 1,000, but probably more by now.
As to their website, I think it is quite spiffy but still a work-in-progress, which only makes sense considering everything that is and has been going on.
http://www.arrayit.com/SARS-CoV-2COVID-19TestInstructions.pdf
Don't worry. It's just in a different place for now:
http://shop.arrayit.com/
Probably part of the plan, while they get their ducks in a row. :))
Bingo! ARYC is under a "notice of suspension of duty to file reports." We already knew this, but good job with your DD.
:))
*lol*
In Italy, if you're over 80 years of age and in need of ICU or urgent care, you're basically toast.
It's really so sad. This pandemic and the associated panic and paranoia is truly a disaster in the making.
I am happy that Arrayit is allowed to do its part to fix it.
As you said:
A lot of people were asymptomatic and this identifies them.
No lies, and your research is incomplete. ARYC does the test with a simple fingerprick and 4 drops of blood. They do this sort of sampling for ALLERGY and ASTHMA testing as well, for which they have been billing millions of dollars per week and that testing is covered by health insurance, including Medicare and Medicaid. Oh, and their lab is a CLIA-certified lab, with all the bells and whistles in place to make Uncle Sam happy.
You're welcome.
Testing accuracy has been excellent in their allergy/asthma program, so why not in the COVID-19 test with the very same sampling method.
Sunnyvale, May 20, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that its clinical laboratory has aced five consecutive rounds of diagnostic immunology proficiency testing (PT) spanning three fiscal years 2017-2019. Proficiency testing requires the precise and accurate measurement of immunoglobulin E (IgE), the cellular biomarkers associated with allergy and asthma and reported in the company’s allergy test reports. A proficiency testing leader ships blinded specimens to Arrayit for testing, and Arrayit tests the specimens and reports the results for scoring to the independent agency. Because the acceptable test range is narrow, acing five consecutive rounds of PT is extremely demanding and requires a high degree of testing accuracy. Outstanding PT scores are valuable commercially because they expedite reimbursement by Medicare, Medicaid and the top commercial payors.
REPOST FROM KRAKI RE: Blood is good.
Here is a link to the FDA regarding testing.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-provides-more-regulatory-relief-during-outbreak-continues-help
The FDA has really loosened the rules and some authority in allowing labs to offer tests is now in the hands of the states (paragraph 4.
Paragraph 6 (right above FDA SUPPORT of DIAGNOSTICS):
This may be particularly relevant to Arrayit, because it discusses serology tests. It look like Arrayit is offering exactly that kind of test.
I would not hold my breath waiting for a public approval notification from the FDA, because these guidelines pre-approve what they Arrayit is offering, as long as they keep the FDA informed and supply the users necessary caveats about the limitations of this test.
Obviously BLOOD IS ACCEPTED or ARYC would not have instructions on how to take a sample and then mail it to their lab on its website. No gooey spit, just a few drops of blood. Duh.
The stock market universe has NO CLUE (yet).
No you don't.
It's not worth anyone's time to defend the company from any of your comments. It's simply assumed that they're untrue, exaggerated, or chronically repeated negative sentiments.
Please provide that list and report back. Thanks.
Be afraid. Be very afraid.
A CLIA certified lab that is right now billing millions a week covered by insurance, including Medicare and Medicare, and expanding its portal count daily, with an all-encompassing allergy test that is 99% pinpointing the problem with the patient leading doctors to prescribe the best course of treatment? Right. Why would anyone want to buy out Arrayit.
Not to mention their participation in COVID-19 testing and all of the other products they sell and/or have in the pipeline.
Think!
Please provide a list of those 2000 labs that excludes Arrayit. Thank you. Oh wait. It doesn't exist!
lolol. Too darn funny.
Don’t you get it? He doesn’t know yet!
So that purchase went to the sell side because you paid less than your bid. Happens all the time, and good for you!
Mark said their test has been submitted for emergency approval. There’s nothing left to say unless/until they’re approved, just like all the other labs.
If you read my post, that was just me speculating. Roche did buy out Genentech for $46.8 BILLION. AND Mark DID say he would not sell the company for less than $10.00/share.
Maybe my post was a little over the top, but not impossible!
Don’t know yet. Hoping for a reply as to context.
Not $10.69, but he DID say (for SURE) that he would never sell Arrayit for less than $10.00/share. Jerry, I was just speculating and trying to figure out why Mark would have used the "f-word" when communicating with a shareholder, so I sort of began speculating, focusing on good things that could happen.
:))
Like.
Was it something like this: Mark said: "Arrayit is going to save the US and in fact the world from that f-ing coronavirus and any future pandemics and/or "all the US government agencies will be using our technology in the near future," and/or "Roche has offered a f-ing $10.69/share to buy us out," and/or "When the f-ing financials are finally released we will be showing PROFITABILITY and NO DEBT and settlement of all litigation."
I hate the f-word and never use it, but in this context, maybe Mark was simply EMPHATICALLY trying to convey what our future looks like.
Das right!
lolol.
Our friend posted this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154359876
Can you tell us what he was he talking about when he used the f word??
What he claims has just a teeny-tiny bit of credibility in my mind, if any at all.
He doesn’t have it. A stomach ache and headache do not cut it. He has no symptoms and if his headache is caused by a fever, it wouldn’t go away with a cup of coffee.
Great advice! It must be exhausting.
"the instrumentation reads and reports test results for the company’s allergy and dietary wellness tests and pipeline tests for ovarian cancer and Parkinson’s Disease (PD)."
Right. The FDA must have thrown it all away since it's been 1 year and 8 months since that purchase. The technology must have a "use by" date just like Cheetos.
Brilliant!
Jul. 16, 2018 6:00 AM ET Arrayit Corporation reports clinical instrumentation sale to FDA
Arrayit (OTCPK:ARYC) announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA), the instrumentation reads and reports test results for the company’s allergy and dietary wellness tests and pipeline tests for ovarian cancer and Parkinson’s Disease (PD).
Arrayit CEO Rene Schena states, “The sale of clinical instrumentation to the FDA advances our personalized medicine initiatives by strengthening ties with the nation’s preeminent regulatory agency. Our transformative healthcare products and services benefit from transparency in the hands of top FDA scientists.”
https://seekingalpha.com/news/3370153-arrayit-corporation-reports-clinical-instrumentation-sale-to-fda